Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Jeffrey L Carson
Dr Jeffrey Carson, currently serving as the Provost, New Brunswick at Rutgers Biomedical and Health Sciences, brings a wealth of experience and leadership to the field of medicine. Formerly the Chief of the Division of General Internal Medicine until 2015, he holds the esteemed position of Distinguished Professor of Medicine and occupies the Richard C. Reynolds, M.D. Chair in General Internal… View more
Overview of Genetic Risk Factors and Aetiologies
Author(s): Sarah Ming Li Tan , Shir Lynn Lim , Marcus EH Ong , et al Added: 9 months ago

Electrophysiology & Arrhythmia

Heart Failure
Vutrisiran Attenuates Cardiac Decline in ATTR-CM, HELIOS-B Analysis Shows
Added: 9 months ago Source:  Radcliffe Cardiology
Transthyretin amyloid cardiomyopathy (ATTR-CM) is a progressive and fatal disease characterised by the deposition of amyloid fibrils in the heart. A new analysis from the HELIOS-B trial has found that key echocardiographic measures are strong predictors of clinical outcomes and that the RNA interference (RNAi) therapeutic vutrisiran attenuates the decline in cardiac function in this patient… View more

Imaging & Diagnostics

Heart Failure
GDMT & Outcomes in HFrEF: Physician-led Multicentre Experience from Sarawak
Author(s): Rebecca Su Li Chew , Bui Khiong Chung , Hwei Sung Ling , et al Added: 2 months ago

Cardiovascular Kidney Metabolic

Guidelines & Statements
ESPRIT: Intensive BP Control Benefits Frail Patients
Added: 4 months ago Source:  Radcliffe Cardiology
Intensive blood pressure (BP) control is beneficial for high-risk hypertensive patients, regardless of their frailty status, according to a new post hoc analysis of the ESPRIT trial.¹ The findings suggest that even severely frail patients can safely achieve cardiovascular benefits from a lower systolic BP target.MethodologyThis analysis was conducted on data from the ESPRIT (Effects of intensive… View more

Demographic

Heart Failure
José-Ángel Cabrera
Research Area(s) / Expertise: Job title: Head of the Cardiology Service
Personal History Born in 1962 in Jaén, Spain, Dr José Ángel Cabrera is a recognized expert in heart anatomy.2 “From a very young age, I had an interest in cardiology. I had a relative, my uncle, whom I saw handle cardiac anatomy in children and how he did cardiovascular imaging. So I went to Granada to study medicine,” he says.3 Academic History He earned his Doctorate in Medicine… View more
THT 2025 Conference Announces its Late-Breaking Scientific Sessions
Added: 1 year ago Source:  THT
THT conference has released its four late-breaking trial sessions for 2025.The fourth annual Technology and Heart Failure Therapeutics conference is set to take place from the 11th to 13th February at Omni Boston Hotel at the Seaport in Boston. Access the full programme here.Late Breaking Clinical Science Session ITuesday 11th February, 09:30 – 10:45am ESTRobotic Surgical Technique for Performing… View more

Heart Failure
Added: 10 months ago Source:  Radcliffe CVRM
AUTHOR: Liam ONeillWhile elevated systolic blood pressure variability (SBPV) is a known risk factor for adverse health outcomes, new research published in the European Heart Journal suggests that the change in SBPV over time is also a critical prognostic indicator. The study found that an increase in visit-to-visit SBPV over a 10-year period was significantly associated with a higher risk of… View more

Prevention & Chronic Conditions

Cardiovascular Kidney Metabolic
Mineralocorticoid Receptor Antagonists in Heart Failure
Author(s): Rishi Sethi , Pravesh Vishwakarma , Akshyaya Pradhan Added: 1 year ago

MI/ACS

Heart Failure
Giuseppe Mancia
Job title: Chairman of the Department of Clinical Medicine and Prevention
Giuseppe Mancia is an Italian physician and scientist internationally recognized for his lifelong contributions to cardiovascular medicine and hypertension research. He has spent the majority of his academic and clinical career in Milan and Monza, Italy, where he has played a central role in shaping modern hypertension research, education, and clinical practice across Europe and worldwide… View more